@article{2995239,
    title = "Greek experience in the use of thermachoiceTM for treating heavy menstrual bleeding: Prospective study",
    author = "Paschopoulos, M. and Lavasidis, L.G. and Vrekoussis, T. and Polyzos, N.P. and Dalkalitsis, N. and Stamatopoulos, P. and Grigoriou, O. and Vlachos, G. and Skolarikos, P. and Adonakis, G. and Goumenou, A. and Lialios, G. and Maroulis, G. and Paraskevaidis, E.",
    journal = "Annals of the New York Academy of Sciences",
    year = "2006",
    volume = "1092",
    pages = "460-465",
    publisher = "Blackwell Publishing Inc.",
    issn = "0077-8923, 1749-6632",
    doi = "10.1196/annals.1365.045",
    keywords = "adult;  amenorrhea;  clinical trial;  conference paper;  female;  follow up;  health service;  human;  major clinical study;  menorrhagia;  menstruation;  menstruation disorder;  multicenter study;  oligomenorrhea;  satisfaction;  article;  balloon dilatation;  catheter ablation;  echography;  Greece;  menorrhagia;  methodology;  middle aged;  pathology;  prospective study;  treatment outcome, Adult;  Balloon Dilatation;  Catheter Ablation;  Female;  Follow-Up Studies;  Greece;  Humans;  Menorrhagia;  Middle Aged;  Prospective Studies;  Treatment Outcome",
    abstract = "Heavy menstrual bleeding (HMB) occurs in a considerable percentage of the general population and is one of the main causes due to which a patient is referred to health services. Despite the efforts for pharmaceutical interventions, the symptom usually persists, therefore operative techniques are needed to control the bleeding. Today, apart from the choice of hysterectomy, other less aggressive techniques have been invented. The first results of the Greek Study Group on Gynecological Endoscopy regarding the use of the ThermachoiceTM device are hereby presented. One hundred patients suffering HMB were treated with the ThermachoiceTM device following a standard protocol designed by the Study Group. The follow-up meetings with the patients were held at 3, 6, 12, 24, and 36 months. It seems that the overall effectiveness rate (96%) is satisfactory and it is similar to the overall effectiveness rate reported in other relevant studies upon the Thermachoice TM device. © 2006 New York Academy of Sciences."
}